Other significant pathways included pathways implicated in breast cancer, among them: actin cytoskeleton, the role of BRCA1 in DNA damage response, paxillin, UVA-induced MAPK, aryl hydrocarbon receptor, ILK, and the molecular mechanisms of cancer-signaling pathways. This evidence concerns the gene PXN and breast carcinoma.